IRIS
MORONCINI, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.095
EU - Europa 4.775
AS - Asia 4.192
SA - Sud America 1.086
Continente sconosciuto - Info sul continente non disponibili 462
AF - Africa 256
OC - Oceania 11
Totale 20.877
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.704
IT - Italia 1.391
SG - Singapore 1.281
VN - Vietnam 894
BR - Brasile 855
RU - Federazione Russa 747
CN - Cina 700
DE - Germania 449
HK - Hong Kong 421
UA - Ucraina 418
SE - Svezia 326
IE - Irlanda 313
FR - Francia 278
TR - Turchia 195
GB - Regno Unito 182
FI - Finlandia 166
BD - Bangladesh 156
CA - Canada 151
DK - Danimarca 149
IN - India 115
CI - Costa d'Avorio 96
NL - Olanda 88
KR - Corea 82
MX - Messico 78
AR - Argentina 70
PL - Polonia 58
JP - Giappone 53
AT - Austria 50
EC - Ecuador 48
ZA - Sudafrica 48
ES - Italia 41
IQ - Iraq 39
MA - Marocco 39
CO - Colombia 35
ID - Indonesia 34
PK - Pakistan 33
IL - Israele 30
NI - Nicaragua 27
CR - Costa Rica 24
VE - Venezuela 22
BE - Belgio 20
CL - Cile 19
PH - Filippine 19
GT - Guatemala 18
HN - Honduras 17
PY - Paraguay 17
TN - Tunisia 17
UZ - Uzbekistan 17
LT - Lituania 15
MY - Malesia 15
SA - Arabia Saudita 15
TT - Trinidad e Tobago 15
SV - El Salvador 13
GP - Guadalupe 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
JM - Giamaica 11
NP - Nepal 11
DZ - Algeria 10
PR - Porto Rico 10
AL - Albania 9
CW - ???statistics.table.value.countryCode.CW??? 9
JO - Giordania 9
AU - Australia 8
PE - Perù 8
RO - Romania 8
RS - Serbia 8
SC - Seychelles 8
UY - Uruguay 8
CH - Svizzera 7
DO - Repubblica Dominicana 7
KE - Kenya 7
PS - Palestinian Territory 7
TW - Taiwan 7
EE - Estonia 6
PT - Portogallo 6
AZ - Azerbaigian 5
ET - Etiopia 5
EU - Europa 5
KZ - Kazakistan 5
OM - Oman 5
TH - Thailandia 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
CZ - Repubblica Ceca 4
GR - Grecia 4
HR - Croazia 4
KW - Kuwait 4
LB - Libano 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
BO - Bolivia 3
GE - Georgia 3
HU - Ungheria 3
IR - Iran 3
MD - Moldavia 3
AM - Armenia 2
GA - Gabon 2
KG - Kirghizistan 2
LU - Lussemburgo 2
Totale 20.390
Salva come PNG Salva come JPEG
Città #
Ashburn 1.722
Singapore 760
Chandler 621
San Jose 583
Dallas 537
Council Bluffs 482
Jacksonville 432
Hong Kong 409
Fairfield 335
Ho Chi Minh City 307
Dublin 305
Boardman 291
Des Moines 264
New York 246
Hanoi 195
Los Angeles 193
Wilmington 192
The Dalles 188
Beijing 186
Houston 155
Woodbridge 155
Centro 149
Lauterbourg 146
Seattle 138
Munich 133
Moscow 132
Ancona 118
Milan 118
Ann Arbor 115
Princeton 115
Lawrence 108
Santa Clara 105
São Paulo 98
Abidjan 96
San Mateo 92
Cambridge 80
Hefei 80
Phoenix 78
Chicago 73
Rome 64
Buffalo 63
Orem 59
Helsinki 55
Nuremberg 52
Turin 48
London 46
Redmond 45
Montreal 44
Atlanta 42
Da Nang 41
Haiphong 41
Tokyo 40
Mexico City 39
Tolentino 38
Turku 38
Warsaw 38
San Diego 37
Shanghai 35
Frankfurt am Main 33
Rio de Janeiro 31
Marche 30
Chennai 29
Brooklyn 28
Johannesburg 28
Salt Lake City 27
Amsterdam 24
Washington 24
Brasília 23
Denver 22
Florence 22
Guangzhou 22
Naples 22
Stockholm 21
Managua 20
Poplar 20
Toronto 20
Vienna 20
Belo Horizonte 19
Boston 17
Jesi 17
Manchester 17
Porto Alegre 17
San Francisco 17
Columbus 16
Pune 16
Brussels 15
Curitiba 15
Tashkent 15
Wuhan 15
Guayaquil 14
Guarulhos 13
Guatemala City 13
Miami 13
Sterling 13
Ankara 12
Baghdad 12
Biên Hòa 12
Bắc Ninh 12
Elk Grove Village 12
Hải Dương 12
Totale 12.197
Salva come PNG Salva come JPEG
Nome #
Insights from comparison of serum IgG4 between T2-eosinophilic asthma and eosinophilic granulomatosis with polyangiitis/idiopathic hypereosinophilic syndrome 267
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud'€™s phEnomenon (SUNSHINE survey) 249
Overview of Curcumin and Piperine Effects on Glucose Metabolism: The Case of an Insulinoma Patient’s Loss of Consciousness 247
The value of admission Troponin I to predict outcomes in suspected infections in elderly patients admitted in Internal Medicine: results from the SOFA-T collaboration, a multi-center study 223
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease 220
The first outstanding 50 years of “Università Politecnica delle Marche”: Research achievements in life sciences 208
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach 200
Development of the optimal touchscreen interface for patients with scleroderma 198
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 197
Atrial Fibrillation on Patients with Vascular Dementia: A Fundamental Target for Correct Management 196
Preface 196
SOFA and qSOFA usefulness for in-hospital death prediction of elderly patients admitted for suspected infection in internal medicine 196
ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics 195
Developments in the management of advanced soft-tissue sarcoma –€“ Olaratumab in context 182
Adalimumab modulates angiogenesis in psoriatic skin 180
Erratum: Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance [Radiol med, DOI 10.1007/s11547-014-0419-7] 173
SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study 172
6 and 12 month outcomes in patients following COVID-19-related hospitalization: a prospective monocentric study 169
Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor α autoantibodies in systemic sclerosis 167
B CELL RECEPTOR EDITING IN SCLERODERMA PATIENTS GENERATES PATHOGENIC ANTI-PDGFR AUTOANTIBODIES 166
Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro 166
A reactive Oxygen species -mediated loop mantains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis 165
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients 164
Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts. 161
Echocardiographic predictors of mortality in intermediate-risk pulmonary embolism 161
Impact of atrial fibrillation in critically ill patients admitted to a stepdown unit 160
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 159
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs. 158
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice 158
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 155
Biosensor-based Binding Assay for Platelet-Derived Growth Factor Receptor-α Autoantibodies in Human Serum 155
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies 155
Analysis of ATP8B4 F436L missense variant in a large systemic sclerosis cohort 154
Hypothalamic-pituitary-adrenal axis disregulation in PrPC-null mice. 151
Improving the EHMRG Prognostic Evaluation of Acute Heart Failure with TAPSE/PASp: A Sequential Approach 149
Risk prediction of clinical adverse outcomes with machine learning in a cohort of critically ill patients with atrial fibrillation 146
Effects of prophylactic drug therapies and anti-calcitonin peptide-related monoclonal antibodies on subjective sleep quality: An Italian multicenter study 145
Clusters of Comorbidities in the Short-Term Prognosis of Acute Heart Failure among Elderly Patients: A Retrospective Cohort Study 143
DETECTION OF STIMULATORY ANTI-PDGF RECEPTOR AUTOANTIBODIES BY BIOASSAYS BASED ON DIFFERENT CELL LINES 140
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis 140
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases 139
AUTOIMMUNITY TO PDGFR: A RELEVANT PATHOGENIC LINK IN SSc 139
Agonistic antibodies in systemic sclerosis 139
Update of EULAR recommendations for the treatment of systemic sclerosis 138
Biologics in inflammatory immune-mediated systemic diseases 138
The Relationship between Post-COVID Syndrome and the Burden of Comorbidities Assessed Using the Charlson Comorbidity Index 136
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 135
Cloning of agonistic autoantibodies specific for the PDGF receptor from the B-cell repertoire of SSc patients 135
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches 135
Cutting-Edge Techniques and Drugs for the Treatment of Pulmonary Embolism: Current Knowledge and Future Perspectives 134
CLONING OF AGONISTIC AUTOANTIBODIES SPECIFIC FOR THE PDGF RECEPTOR FROM THE B CELL REPERTOIRE OF PATIENTSAFFECTED BY SYSTEMIC SCLEROSIS 131
Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis 131
Implementation of EHMRG Risk Model in an Italian Population of Elderly Patients with Acute Heart Failure 130
WIF1, A WNT PATHWAY INHIBITOR, IS SILENCED IN SYSTEMIC SCLEROSIS BY DNA DAMAGE: A MECHANISM LINKING DNA DAMAGE TO WNT AND FIBROSIS 130
Mechanism of action of agonistic PDGFR auto-antibodies isolated from scleroderma patients 130
The Wnt signalling inhibitor gene, WIF1, is silenced in fibroblasts derived from Systemic Sclerosis patients: role of oxidative stress 130
Immunohistochemical detection and localization of somatostatin receptor subtypes in prostate tissue from patients with bladder outlet obstruction. 129
Pathogenic autoantibodies in systemic sclerosis 129
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis 129
History and scientific production of clinica medica and clinica ematologica in ancona 129
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis 128
Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin 128
Clinical method applied to focused ultrasound: The case of wells’ score and echocardiography in the emergency department: A systematic review and a meta-analysis 128
Contributions of neuronal prion protein on sleep recovery and stress response following sleep deprivation. 127
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?' 127
Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trial 126
Autoantibodies against the platelet-derived growth factor receptor in scleroderma: comment on the articles by Classen et al and Loizos et al. 126
NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis 126
BIOLOGIC THERAPY IN INFLAMMATORY IMMUNOMEDIATED SYSTEMIC DISEASES: SAFETY PROFILE 126
Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis 125
Detection of typical and atypical bovine spongiform encephalopathy and scrapie prion strains by prion protein motif-grafted antibodies. 125
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 125
Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance 122
Putative functional pathogenic autoantibodies in systemic sclerosis 122
Common Variable Immunodeficiency in Elderly Patients: A Long-Term Clinical Experience 122
Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited. 121
MOTIF-GRAFTED HYBRID POLYPEPTIDES AND USES THEREOF 120
Reactivation of Hepatitis B Virus Infection Associated with Anti-Tumor Necrosis Factor-α Therapy 120
Detection of typical and atypical BSE and scrapie prion strains by prion protein motif-grafted antibodies. 119
Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway 119
Oxidative DNA damage induces the ATM-mediated transcriptional suppressionof the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis 118
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways 117
Development of A Solid Phase Binding Assay For Detection of Conformational Anti-PDGFR Autoantibodies In the Serum of Patients Affected By Scleroderma 115
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 115
Treatment With Rituximab Reduces Activation Of Scleroderma Dermal Fibroblasts 115
Downregulation of GPR83 in the hypothalamic preoptic area reduces core body temperature and elevates circulating levels of adiponectin. 115
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 114
Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets 114
Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab 114
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 114
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort 113
Scleroderma-like fibrosis in chronic graft-vs-host disease is sustained by anti-PDGF receptors antibodies 113
PDGF receptor as therapeutic and diagnostic target in systemic sclerosis 112
Delection of typical and atypical bovine spongiform encephalopathy and scraipe prion strains by prion protein motif-grafted antibodies 111
Role of viral infections in the etiopathogenesis of systemic sclerosis 111
Low-dose Oral Imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide. A phase II pilot study 111
Axial psoriatic arthritis in patients not fulfilling the back pain entry features of the ASAS Classification Criteria for Axial Spondyloarthritis: findings from the ATTRACT Study 109
Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress 109
Platelet-activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy? 109
Development of a conformation-dependent immunoassay for the diagnosis of systemic sclerosis 108
Totale 14.491
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.013
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.013
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022579 0 0 0 0 22 43 20 53 83 57 125 176
2022/20231.821 148 189 128 162 113 403 9 101 382 24 122 40
2023/20241.153 163 38 66 138 167 233 21 51 11 82 57 126
2024/20252.871 319 259 75 48 128 119 345 128 585 190 282 393
2025/20268.821 581 639 650 909 962 516 1.513 782 736 743 404 386
2026/20272.398 580 360 404 980 74 0 0 0 0 0 0 0
Totale 20.877